Review





Similar Products

94
Elabscience Biotechnology fgf21
Fgf21, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf21/Mouse+FGF21+(Fibroblast+Growth+Factor+21)+ELISA+Kit/pm42869365-150-38-39
Average 94 stars, based on 1 article reviews
fgf21 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

93
Elabscience Biotechnology elabscience human fgf21
Elabscience Human Fgf21, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf21/Human+FGF21+(Fibroblast+Growth+Factor+21)+ELISA+Kit/pm42860768-72-5-5
Average 93 stars, based on 1 article reviews
elabscience human fgf21 - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Elabscience Biotechnology human fgf21 elisa kit
Human Fgf21 Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf21/Human+FGF21+(Fibroblast+Growth+Factor+21)+ELISA+Kit/pm42834225-394-19-23
Average 93 stars, based on 1 article reviews
human fgf21 elisa kit - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

94
RayBiotech inc fgf 21
Circulating biomarkers levels in chronic heart failure patients and controls
Fgf 21, supplied by RayBiotech inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf21/Human+FGF-21+ELISA/pmc13650993-96-6-12
Average 94 stars, based on 1 article reviews
fgf 21 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
ABclonal Biotechnology fgf 21
Circulating biomarkers levels in chronic heart failure patients and controls
Fgf 21, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf21/FGF21+Rabbit+pAb/10__1016_slash_j__bioadv__2026__215236-176-1-43
Average 94 stars, based on 1 article reviews
fgf 21 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
ABclonal Biotechnology anti fgf21 187
Circulating biomarkers levels in chronic heart failure patients and controls
Anti Fgf21 187, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf21/FGF21+Rabbit+pAb/10__1016_slash_j__gendis__2026__102457-94-45-48
Average 94 stars, based on 1 article reviews
anti fgf21 187 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
ABclonal Biotechnology fgf21
Circulating biomarkers levels in chronic heart failure patients and controls
Fgf21, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf21/FGF21+Rabbit+pAb/pm42463639-233-5-13
Average 94 stars, based on 1 article reviews
fgf21 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

94
ABclonal Biotechnology goat serum
Circulating biomarkers levels in chronic heart failure patients and controls
Goat Serum, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf21/FGF21+Rabbit+mAb/pm41967776-115-7-22
Average 94 stars, based on 1 article reviews
goat serum - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

Image Search Results


Circulating biomarkers levels in chronic heart failure patients and controls

Journal: ESC Heart Failure

Article Title: Integrated miRNA-cytokine profiling reveals a molecular signature of cachexia in patients with chronic heart failure

doi: 10.1093/eschf/xvag229

Figure Lengend Snippet: Circulating biomarkers levels in chronic heart failure patients and controls

Article Snippet: Serum concentrations of GDF-15 (#ELH-GDF15-1) and FGF-21 (#ELH-FGF21-1) were measured using ELISA (RayBiotech, Norcross, GA, USA) according to manufacturers’ instructions.

Techniques:

Circulating miRNAs and cytokines as molecular signatures of heart failure. Differences in serum levels of GDF-15 and FGF-21 in CHF patients and controls. Serum levels of GDF-15 by ELISA assay in patients with heart failure (HF) ( n = 25) and the control group ( n = 10). ( A ) Data showed significant upregulation of GDF-15 in CHF vs controls ( P < .001). ( B ) FGF-21 levels did not differ significantly between groups. Correlations between GDF-15 and selected miRNAs in CHF patients. ( C , D ) In CHF patients, GDF-15 levels were positively associated with miR-29b ( ρ = 0.42, P = .037) and miR-486 ( ρ = 0.42, P = .039). Data are expressed as fold change and are presented as mean ± SEM. Student's t -test or Mann–Whitney test was used for normally distributed data or non-normally distributed data, respectively. *** P ≤ .001.

Journal: ESC Heart Failure

Article Title: Integrated miRNA-cytokine profiling reveals a molecular signature of cachexia in patients with chronic heart failure

doi: 10.1093/eschf/xvag229

Figure Lengend Snippet: Circulating miRNAs and cytokines as molecular signatures of heart failure. Differences in serum levels of GDF-15 and FGF-21 in CHF patients and controls. Serum levels of GDF-15 by ELISA assay in patients with heart failure (HF) ( n = 25) and the control group ( n = 10). ( A ) Data showed significant upregulation of GDF-15 in CHF vs controls ( P < .001). ( B ) FGF-21 levels did not differ significantly between groups. Correlations between GDF-15 and selected miRNAs in CHF patients. ( C , D ) In CHF patients, GDF-15 levels were positively associated with miR-29b ( ρ = 0.42, P = .037) and miR-486 ( ρ = 0.42, P = .039). Data are expressed as fold change and are presented as mean ± SEM. Student's t -test or Mann–Whitney test was used for normally distributed data or non-normally distributed data, respectively. *** P ≤ .001.

Article Snippet: Serum concentrations of GDF-15 (#ELH-GDF15-1) and FGF-21 (#ELH-FGF21-1) were measured using ELISA (RayBiotech, Norcross, GA, USA) according to manufacturers’ instructions.

Techniques: Enzyme-linked Immunosorbent Assay, Control, MANN-WHITNEY

Molecular profiles in CHF patients. Differences in serum levels of GDF-15 and FGF-21 among heart failure patients with and without cardiac cachexia. Circulating levels of GDF-15 and FGF-21 were analyzed in CHF patients with cardiac cachexia (CC) ( n = 10) and without cardiac cachexia (nCC) ( n = 15), and a control group ( n = 10). ( A ) Significant difference in GDF-15 levels was observed between patients with CC or nCC vs controls (all P < .001). ( B ) Levels of FGF-21 were significantly higher in CHF with CC compared with nCC ( P = .012) and vs controls ( P = .010) ( C ). Spearman’s correlation analysis revealed that in CHF patients with CC, GDF-15 negatively correlated with miR-21 ( ρ = −0.81, P = .007). ( D ) In the same group, FGF-21 negatively correlated with miR-486 ( ρ = −0.69, P = .035). Data are expressed as fold change and are presented as mean ± SEM. One-way ANOVA test or Kruskal–Wallis test was used for normally distributed data or non-normally distributed data, respectively. * P < .05, *** P ≤ .001.

Journal: ESC Heart Failure

Article Title: Integrated miRNA-cytokine profiling reveals a molecular signature of cachexia in patients with chronic heart failure

doi: 10.1093/eschf/xvag229

Figure Lengend Snippet: Molecular profiles in CHF patients. Differences in serum levels of GDF-15 and FGF-21 among heart failure patients with and without cardiac cachexia. Circulating levels of GDF-15 and FGF-21 were analyzed in CHF patients with cardiac cachexia (CC) ( n = 10) and without cardiac cachexia (nCC) ( n = 15), and a control group ( n = 10). ( A ) Significant difference in GDF-15 levels was observed between patients with CC or nCC vs controls (all P < .001). ( B ) Levels of FGF-21 were significantly higher in CHF with CC compared with nCC ( P = .012) and vs controls ( P = .010) ( C ). Spearman’s correlation analysis revealed that in CHF patients with CC, GDF-15 negatively correlated with miR-21 ( ρ = −0.81, P = .007). ( D ) In the same group, FGF-21 negatively correlated with miR-486 ( ρ = −0.69, P = .035). Data are expressed as fold change and are presented as mean ± SEM. One-way ANOVA test or Kruskal–Wallis test was used for normally distributed data or non-normally distributed data, respectively. * P < .05, *** P ≤ .001.

Article Snippet: Serum concentrations of GDF-15 (#ELH-GDF15-1) and FGF-21 (#ELH-FGF21-1) were measured using ELISA (RayBiotech, Norcross, GA, USA) according to manufacturers’ instructions.

Techniques: Control, Analysis

Molecular profiles in cachectic patients with severe CHF. FGF-21 concentrations and their associations with NYHA functional class in patients with CHF. ( A ) Data show higher FGF-21 levels in NYHA class III-IV ( n = 13) compared with class I-II ( n = 9) ( P = .050) and the control group ( n = 10) ( P = .050). ( B ) In NYHA class III-IV, FGF-21 positively correlated with miR-15b ( r = 0.68, P = .014). Data are expressed as fold change and are presented as mean ± SEM. One-way ANOVA test or Kruskal–Wallis test was used for normally distributed data or non-normally distributed data, respectively. * P < .05.

Journal: ESC Heart Failure

Article Title: Integrated miRNA-cytokine profiling reveals a molecular signature of cachexia in patients with chronic heart failure

doi: 10.1093/eschf/xvag229

Figure Lengend Snippet: Molecular profiles in cachectic patients with severe CHF. FGF-21 concentrations and their associations with NYHA functional class in patients with CHF. ( A ) Data show higher FGF-21 levels in NYHA class III-IV ( n = 13) compared with class I-II ( n = 9) ( P = .050) and the control group ( n = 10) ( P = .050). ( B ) In NYHA class III-IV, FGF-21 positively correlated with miR-15b ( r = 0.68, P = .014). Data are expressed as fold change and are presented as mean ± SEM. One-way ANOVA test or Kruskal–Wallis test was used for normally distributed data or non-normally distributed data, respectively. * P < .05.

Article Snippet: Serum concentrations of GDF-15 (#ELH-GDF15-1) and FGF-21 (#ELH-FGF21-1) were measured using ELISA (RayBiotech, Norcross, GA, USA) according to manufacturers’ instructions.

Techniques: Functional Assay, Control

Schematic representation of the circulating molecular profile associated with chronic heart failure and cardiac cachexia, characterized by dysregulation of muscle- and remodelling-related miRNAs and increased stress-responsive cytokines. CHF patients showed reduced miR-15b, miR-29b, miR-133a, and miR-486 and increased GDF-15, while cardiac cachexia was further associated with lower miR-29b and higher FGF-21 levels.

Journal: ESC Heart Failure

Article Title: Integrated miRNA-cytokine profiling reveals a molecular signature of cachexia in patients with chronic heart failure

doi: 10.1093/eschf/xvag229

Figure Lengend Snippet: Schematic representation of the circulating molecular profile associated with chronic heart failure and cardiac cachexia, characterized by dysregulation of muscle- and remodelling-related miRNAs and increased stress-responsive cytokines. CHF patients showed reduced miR-15b, miR-29b, miR-133a, and miR-486 and increased GDF-15, while cardiac cachexia was further associated with lower miR-29b and higher FGF-21 levels.

Article Snippet: Serum concentrations of GDF-15 (#ELH-GDF15-1) and FGF-21 (#ELH-FGF21-1) were measured using ELISA (RayBiotech, Norcross, GA, USA) according to manufacturers’ instructions.

Techniques: